Skip to content

Intramed Side Branch Occlusion (Sbo) System (700095 and 700099)

by Baxter Edwards

510(k) K964021

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK964021 Date27 Mar 1997ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
HCG
Device Class
Class II
Regulation
21 CFR Part 882.5950
Advisory Committee
Neurology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Intramed Side Branch Occlusion (SBO) System is a neurovascular embolization device designed for the occlusion of side branches in cerebral arteries. It consists of occlusion coils intended to block blood flow through unwanted vessels, such as arteriovenous malformations or aneurysms, during interventional neuroradiology procedures. The system aids in reducing blood supply to targeted vascular abnormalities, thereby supporting therapeutic interventions in neurology.

The system is supplied as a sterile, single-use device and includes an introducer catheter with a composite shaft featuring two lumens. It is intended for use in MRI-safe environments and is regulated under FDA 510(k) clearance (K964021) as a Class II device (HCG product code). Storage and handling must comply with sterile medical device protocols, and its design adheres to regulatory standards for neurovascular embolization tools.

Other devices from Baxter Edwards

See all devices from Baxter Edwards →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Intramed SBO System (700095/700099) used for?

    The Intramed Side Branch Occlusion (SBO) System is designed specifically for neurovascular embolization procedures. It blocks unwanted blood flow in cerebral arteries, such as those supplying arteriovenous malformations or aneurysms, to reduce perfusion to targeted vascular abnormalities. This supports therapeutic interventions in neurology by isolating problematic vessels during interventional neuroradiology.

  • How is the Intramed SBO System supplied and what are its sterility and reuse details?

    The Intramed SBO System is supplied as a sterile, single-use device. Each kit is individually packaged to maintain sterility and is not intended for reuse. Adherence to sterile medical device protocols during storage and handling is critical to preserve its integrity and functionality for clinical use.

  • Does the system include a catheter, and what are its key features?

    Yes, the system includes an introducer catheter with a composite shaft featuring two lumens. This design facilitates precise delivery of occlusion coils to the targeted side branches in cerebral arteries, ensuring effective embolization during procedures.

  • Can the Intramed SBO System be used in MRI environments?

    The Intramed SBO System is explicitly designed for use in MRI-safe environments. This ensures compatibility with magnetic resonance imaging equipment, reducing the risk of interference or safety concerns during neurovascular procedures.

  • What regulatory pathway does this device follow, and what class is it assigned?

    The Intramed SBO System follows the FDA 510(k) clearance pathway and is classified as a Class II device under the HCG product code. It was granted clearance in 1997 under the decision code SESE (Substantially Equivalent) by Baxter Edwards, with the advisory committee designation for Neurology (NE).